Study of a new medicine for type 2 diabetes and healthy volunteers
Part of Hormones & metabolism clinical trials.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be male or a female who cannot become pregnant.
- If you are healthy, you must be between 18 and 45 years old with a BMI between 18.5 and 29.9.
- If you have type 2 diabetes, you must be between 18 and 64 years old with a BMI between 20.0 and 34.9.
- Your blood sugar control (HbA1c) must be within certain ranges: below 6.4% for healthy people, or between 6.5% and 9.0% for those with diabetes.
- You must not have significant liver, kidney, or heart problems.
- If you have diabetes, you must have been diagnosed at least 6 months ago and be on a stable dose of metformin (with or without certain other diabetes medicines) for the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called GUB-UCN2 in people who are healthy, overweight, or have type 2 diabetes. The goal is to see if the drug is safe and how the body processes it.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.